Synthorx

SynthRox is a biotechnology company that utilizes synthetic biology to synthesize solutions. Synthorin cytokines can selectively modulate receptor pharmacology and extend half-life. These characteristics effectively activate the immune system, enhancing the anti-tumor activity of current major cancer immunotherapies, including checkpoint inhibitors, cancer vaccines, CAR-T therapies, and oncolytic viruses, when administered at appropriate doses.